MyFinsight
Home
Blog
About
Contact
Download
Download image
Proprietary Products
$2,492,100K
(6.75%↑ Y/Y)
Contract Manufactured
Products
$582,000K
(4.17%↑ Y/Y)
Net sales
$3,074,100K
(6.25%↑ Y/Y)
Gross profit
$1,104,000K
(10.57%↑ Y/Y)
Cost of goods and
services sold
$1,970,100K
(3.98%↑ Y/Y)
Operating profit
$584,900K
(2.63%↑ Y/Y)
Interest income
$17,500K
(-10.71%↓ Y/Y)
Selling, general and
administrative expenses
$393,600K
(16.28%↑ Y/Y)
Research and development
$74,300K
(7.53%↑ Y/Y)
Other expense
(income) (note 16)
-$51,200K
(-143.81%↓ Y/Y)
Income before income
taxes and equity in net...
$600,900K
(2.63%↑ Y/Y)
Equity in net income of
affiliated companies
$14,400K
(-2.04%↓ Y/Y)
Other nonoperating
expense (income)
-$1,000K
(0.00%↑ Y/Y)
Interest expense
$500K
(-83.33%↓ Y/Y)
Total restructuring
and related charges
$24,600K
(1084.00%↑ Y/Y)
Contingent consideration
$8,700K
(70.59%↑ Y/Y)
Foreign exchange
transaction losses
-$8,400K
(17.65%↑ Y/Y)
Asset impairments
$8,200K
(12.33%↑ Y/Y)
Other items
-$1,300K
(-44.44%↓ Y/Y)
Net income
$493,700K
(0.20%↑ Y/Y)
Income tax expense
$121,600K
(13.12%↑ Y/Y)
Severance and benefits
$19,200K
(868.00%↑ Y/Y)
Asset-related charges
$5,400K
Back
Back
Income Statement
source: myfinsight.com
WEST PHARMACEUTICAL SERVICES INC (WST)
WEST PHARMACEUTICAL SERVICES INC (WST)